These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36630964)

  • 1. Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease.
    Krishnaraj A; Bakbak E; Teoh H; Bhatt DL; Quan A; Puar P; Lambotharan B; Kirubaharan A; Firoz IN; Meglis G; Yanagawa B; Bari B; Kirubaharan R; Vijayaraghavan R; Hess DA; Demchuk AM; Mancini GBJ; Tanguay JF; Tardif JC; Voisine P; Leiter LA; Verma S
    Med; 2023 Feb; 4(2):130-138.e1. PubMed ID: 36630964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
    Chapman MJ; Zamorano JL; Parhofer KG
    Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk.
    Orringer CE; Jacobson TA; Maki KC
    J Clin Lipidol; 2019; 13(6):860-872. PubMed ID: 31787586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAC for Risk Stratification Among Individuals With Hypertriglyceridemia Free of Clinical Atherosclerotic Cardiovascular Disease.
    Cainzos-Achirica M; Quispe R; Dudum R; Greenland P; Lloyd-Jones D; Rana JS; Lima JAC; Doria de Vasconcellos H; Joshi PH; Khera A; Ayers C; Erbel R; Stang A; Jöckel KH; Lehmann N; Schramm S; Schmidt B; Toth PP; Patel KV; Blaha MJ; Bittencourt M; Nasir K
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):641-651. PubMed ID: 34922873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.
    Haque W; Grandhi GR; Kanaya AM; Kandula NR; Nasir K; Al Rifai M; Uddin SMI; Fedeli U; Sattar N; Blumenthal RS; Blaha MJ; Cainzos-Achirica M
    Atherosclerosis; 2021 Oct; 334():48-56. PubMed ID: 34481175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements.
    Miller M; Tokgozoglu L; Parhofer KG; Handelsman Y; Leiter LA; Landmesser U; Brinton EA; Catapano AL
    Expert Rev Cardiovasc Ther; 2022 Aug; 20(8):609-625. PubMed ID: 35876118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system.
    Mantri NM; Merchant M; Rana JS; Go AS; Pursnani SK
    BMC Cardiovasc Disord; 2022 Dec; 22(1):566. PubMed ID: 36564709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies.
    Saeed A; Virani SS; Mulukutla S; Chow CK
    Curr Diabetes Rev; 2021; 17(9):e011221190238. PubMed ID: 33438542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial.
    Bakbak E; Krishnaraj A; Bhatt DL; Quan A; Park B; Bakbak AI; Bari B; Terenzi KA; Pan Y; Fry EJ; Terenzi DC; Puar P; Khan TS; Rotstein OD; Mazer CD; Leiter LA; Teoh H; Hess DA; Verma S
    Med; 2024 Jul; 5(7):718-734.e4. PubMed ID: 38552629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.
    Kandula NR; Kanaya AM; Liu K; Lee JY; Herrington D; Hulley SB; Persell SD; Lloyd-Jones DM; Huffman MD
    J Am Heart Assoc; 2014 Oct; 3(5):e001117. PubMed ID: 25277669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterol.
    Bazarbashi N; Miller M
    Expert Rev Cardiovasc Ther; 2020 Apr; 18(4):175-180. PubMed ID: 32228246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB; Nordestgaard BG
    JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.
    Boden WE; Bhatt DL; Toth PP; Ray KK; Chapman MJ; Lüscher TF
    Eur Heart J; 2020 Jun; 41(24):2304-2312. PubMed ID: 31872245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.
    Wong ND; Zhao Y; Xiang P; Coll B; López JAG
    Am J Cardiol; 2020 Dec; 137():7-11. PubMed ID: 32991855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
    Budoff MJ; Muhlestein JB; Bhatt DL; Le Pa VT; May HT; Shaikh K; Shekar C; Kinninger A; Lakshmanan S; Roy SK; Tayek J; Nelson JR
    Cardiovasc Res; 2021 Mar; 117(4):1070-1077. PubMed ID: 32609331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
    Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
    JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
    Budoff MJ; Bhatt DL; Kinninger A; Lakshmanan S; Muhlestein JB; Le VT; May HT; Shaikh K; Shekar C; Roy SK; Tayek J; Nelson JR
    Eur Heart J; 2020 Oct; 41(40):3925-3932. PubMed ID: 32860032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.